Claire E. O'Hanlon is a doctoral candidate at the Pardee RAND Graduate School and an assistant policy researcher at the RAND Corporation. Her current work focuses on value and quality in health care, end-of-life and advance care planning, and evidence-based medicine. Her dissertation is on the effects of health care industry consolidation in the United States. O'Hanlon also currently serves as the On-the-Job Training Broker for Pardee RAND Graduate School and RAND Health. She was a graduate intern in health economics at Amgen during summer 2016.
O'Hanlon was previously a research assistant at University of Chicago Medicine, where she worked on validating prognostic models. During this time, she was a business development intern at Knopp Biosciences, a biotechnology start-up, where she developed a pharmacoeconomic model of Parkinson’s disease. Prior to her career in health policy and outcomes research, she was a laboratory technician at Duquesne University, where she designed drug delivery agents.
O'Hanlon holds a Master of Public Policy from the University of Chicago Harris School, a certificate in Health Administration and Policy from the University of Chicago, and a B.S. in engineering from Harvey Mudd College.
O’Hanlon CE, Parthan A, Kruse M, Cartier S, Stollenwerk B, Jiang Y, Caloyeras J, Crittenden DB, Barron R, "A model for assessing the clinical and economic benefits of bone-forming osteoporosis agents in reducing fractures in post-menopausal women at high, near-term risk of fragility fracture," Clinical Therapeutics, 0, 2017
Mullins L, O’Hanlon CE, Shadel W, Tucker JS, "A qualitative study of smoking cessation experiences and perceptions among homeless young adults," Journal of Social Distress and the Homeless, 0, 2017
Chari R, O’Hanlon C, Chen P, Leuschner K, Nelson C, "Governing academic medical center systems: evaluating and choosing among alternative governance approaches," Academic Medicine, 0, 2017
O’Hanlon CE, Cooper JM, Lee SM, John P, Churpek M, Chin MH, Huang ES, "Life expectancy predictions for older diabetic patients as estimated by physicians and a prognostic model," Medical Decision Making Policy & Practice, 0, 2017
O’Hanlon C, Huang C, Sloss E, Anhang Price R, Hussey P, Farmer C, Gidengil C, "Comparing VA and non-VA quality of care: a systematic review," Journal of General Internal Medicine, 0, 2016
O'Hanlon CE, Newberry SJ, Booth M, Grant S, Motala A, Maglione MA, FitzGerald JD, Shekelle PG, "Hyaluronic acid injection therapy for osteoarthritis of the knee: concordant efficacy and conflicting serious adverse events in two systematic reviews," Systematic Reviews, 0, 2016
Linnemayr SG, O’Hanlon CE, Uscher-Pines L, Van Abel K, Nelson C, "Using insights from behavioral economics to strengthen disaster preparedness and response," Disaster Medicine and Public Health Preparedness, 0, 2016
O'Hanlon CE, Amede KG, O'Hear MR, Janjic JM, "NIR-labeled perfluoropolyether nanoemulsions for drug delivery and imaging," Journal of Fluorine Chemistry, 0, 2012